NAD+ and reproductive aging in mice

Reproductive aging was studied in mice

The study discussed here examined age-associated changes in oocyte quality and NAD-related metabolism in mice. Although the Japanese archive's headline refers to older women, the intervention findings described in the article are not evidence of improved fertility in women.

Oocytes are the cells that can develop into eggs. Their ability to complete maturation, be fertilized and support early embryo development is important to reproductive success. Researchers investigated whether changes in NAD+ availability might contribute to age-associated changes in those processes.

Why oocyte quality matters

The archive discusses chromosome segregation, mitochondrial function, oxidative stress and the systems that monitor cell division. These are possible contributors to changes in oocyte quality. Understanding a mechanism, however, is different from demonstrating a safe treatment for infertility.

The study also examined SIRT2, an NAD+-dependent enzyme. Some observations associated with NMN treatment could be reproduced through experimental SIRT2 overexpression, while loss of SIRT2 did not produce all of the expected changes. That complexity is a reason to avoid reducing the findings to a single “rejuvenation switch.”

How the experiment approached measurement

Measuring NAD-related compounds in a small number of oocytes is technically difficult. The researchers used hyperspectral imaging that takes advantage of the natural fluorescence of NADH and NADPH to examine relevant metabolic changes.

In one experiment described in the archive, 12-month-old female mice received NMN in their drinking water for four weeks before mature oocytes were collected. The investigators reported age-associated changes in the oocyte measurements and increases after the intervention. Measurements in whole ovaries did not show the same simple age-related pattern.

Findings and the limits of interpretation

The study reported changes in oocyte quality and reproductive outcomes in aged animals, and also considered effects on developing embryos. These findings support further investigation of NAD-related metabolism in reproductive biology.

They do not demonstrate that NMN reverses a woman's reproductive age, increases the chance of a live birth after human fertility treatment, or is safe during conception, pregnancy or breastfeeding. An animal dose or treatment schedule must not be converted into personal supplement advice.

Research is not a substitute for fertility care

Reproductive aging is a time-sensitive clinical subject. Experimental findings should not be used to delay assessment or replace established fertility care. The cited study did not test a finished GAAH product.

Cited research: Cell Reports research on NAD+ repletion and age-associated changes in oocyte quality. English editorial edition of the existing GAAH archive.